Stephanie Lobaugh, MS

Research Biostatistician
Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Career Opportunities
Educational Opportunities
Departmental Newsletter

Stephanie Lobaugh, MS

Research Biostatistician
Share
Share
Stephanie Lobaugh

Email

[email protected]

Education

University of North Carolina at Chapel Hill

Current Research Interest 

Stephanie is interested in the application of biostatistical methods to many areas of oncology including diagnostic imaging, assessing adherence to colorectal cancer screening methods, cancer genomics, gynecologic oncology, and cancer survivorship. Additionally, she is interested in characterizing patterns of care and the adoption of care guidelines through population-based studies using Medicare claims data. Currently, she is excited to contribute to research aimed at elucidating the relationship between clonal hematopoiesis and cancer. She is also a member of the Bridge to Biostats committee and helps to organize the “biostats track” within MSK’s Summer Exposure Program for high school students.

Publications

  1. Gollub MJ, Lobaugh S, Golia Pernicka JS, Simmers CDA, Bates DDB, Fuqua JL 3rd, Paroder V, Petkovska I, Weiser MR, Capanu M. Occurrence of peritoneal carcinomatosis in patients with rectal cancer undergoing staging pelvic MRI: clinical observations. Eur Radiol. 2022 Mar 22. doi: 10.1007/s00330-022-08694-7. Epub ahead of print. PMID: 35319077.
  2. Anne S Reiner, MPH, Stephanie M Lobaugh, MS, Selin Gonen, Eli L Diamond, MD, Katherine S Panageas, DrPH, A Population-Based Study of Treatment and Survival in Older Glioma Patients, JNCI Cancer Spectrum, Volume 6, Issue 1, February 2022, pkac010, https://doi.org/10.1093/jncics/pkac010
  3. Zelefsky MJ, Yamada Y, Greco C, Lis E, Schöder H, Lobaugh S, Zhang Z, Braunstein S, Bilsky MH, Powell SN, Kolesnick R, Fuks Z. Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer. International Journal of Radiation Oncology, Biology, Physics. 2021 Jul 1;110(3):672-679.
  4. Santos PMG, Lapen K, Zhang Z, Lobaugh S, Tsai CJ, Yang TJ, Bekelman JE, Gillespie EF. Trends in Radiation Therapy for Bone Metastases, 2015 to 2017: Choosing Wisely in the Era of Complex Radiation. International Journal of Radiation Oncology, Biology, Physics. 2021 Mar 15;109(4):923-931.
  5. Lin RJ, Lobaugh SM, Pennisi M, Chan HT, Batlevi Y, Ruiz JD, Elko TA, Maloy MA, Batlevi CL, Dahi PB, Giralt SA, Hamlin PA, Mead E, Noy A, Palomba ML, Santomasso BD, Sauter CS, Scordo M, Shah GL, Korc-Grodzicki B, Kim SJ, Silverberg ML, Brooklyn CA, Devlin SM, Perales MA. Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma. Haematologica. 2021 Jan 1;106(1):255-258.